CWity51￿l ueenscourt Hospice TRUSTEE ANNUAL REPORT & ACCOUNTS To31st March 2024 11,309, 1,102 3,ioo HOURS OF CARE PROVIDED BY QUEENSCOURT CONTAcfs PROVIDED BY PATIENTS V SUPPORTED QUEENSCOURT THERAPY SERVICES AT HOME 186,075 ITEMS 96,000 RECOR FUNDRAISIN INCOME O 4 MILLION RAISED BY OVER DONATED CUSTOMERS SERVED AT RE UEENSCOURT IAIL SHOPS PLAYING LOThERY MEMBERS SINCE 1994 £742,00 1,100+ 1,671 795 PARTICIPANTS ATfENDED QUEENSCOURT REMEMBRANCE ATTENDED OURANNUAL STAR TREKK EVENT 3,190 EVENTS AThENDANCES AT EDUCATION ADMISSIONS TO VIRTUAL WARD SESSIONS r*V.&W4¥ dellvering exceptkonw compasslonate care for over 30 years o:-a Th• Qu••n'5Award lorVoluntary5*r¥l<• Queenscourt Hospice (Registered number 2102320} Report of the Trustees for the year ended 31st March 2024 Report ofthe C1￿1r Impad Statement Report of the Trustees Report of the Indeperdent Auditors 15-17 Statement of Financial Activitses {InCOrF￿ratIn9 Income & Expenditure Account) 18-19 Balance Sheet 20-21 Cash Flow Statement 22 Notes to the Cash Flow Statement Notes to the Financial Statements ueenscourt i-lospice where life is for Ilvlng... **Queenscourt Hospice (Registered number 2102320)** ## **Report of the Trustees for the year ended 31[st] March 2024 (continued)** ## **Chair’s Foreword** From its inception and certainly as long as I have been associated with it, Queenscourt Hospice has valued a clear and well-developed culture of consistent development and improvement in both our services and our governance. During the past year, this was demonstrated by two key developments. The first was the introduction of the Virtual Ward. Our senior medical and clinical team have pioneered and led this initiative, which is covered in more detail elsewhere in this report. It has once more put the Hospice at the cutting edge of the development of Hospice care in the UK. The second is the work we have been doing as a Council of Trustees and senior team to develop a more robust Board Assessment Framework. This approach will enhance our ability to manage and mitigate existing and emerging risks, enhancing our ability to provide robust governance and support to the organisation. The new framework will provide us, as a Council of Trustees, with improved and streamlined reporting and accountability. We will make greater and more effective use of our subcommittee structure, using the Advice, Alert and Assure approach for reporting to the full Council. In depth challenge and review by Trustees at subcommittee level will result in continued improvement of our organisational governance and assurance. Our Impact Statement is based on a thorough analysis of how and where we provide key support. However, what it really shows is the enormous difference our services have made and continue to make to our local communities. I am immensely proud of our achievements. Once again, this year, the staff of Queenscourt have worked wonders for the patients and those closest to them. I will never stop feeling humbled by the wonderful services they provide. Their professionalism and care have ensured that our patients receive compassionate human contact when they needed it most. I am in awe at the commitment and compassion of the entire team at Queenscourt. I never tire of singing their praises. When I refer to the entire team at Queenscourt, I am also, of course, including the administrative staff. They have provided essential support and continued to work to not only keep Queenscourt ticking over but to strive for improvements and greater efficiency wherever they can. Their dedication and commitment is outstanding and alongside the patient-facing staff, forms the foundation of our continuing existence. I would like to place on record my gratitude to my fellow members of Queenscourt Council. They provide their skills, wisdom and enthusiasm to support and challenge the Directors and staff to achieve even greater levels of excellence and care. The Council operates within the framework of law and practice established by several regulatory authorities, meaning that we are held to very high standards in the performance of our duties We maintain a wide variety of backgrounds and expertise on Council, through ongoing review and recruitment, to ensure we meet all of those requirements. I would also like to place on record my gratitude to our communities for their support, both in terms of money contributed and in terms of the time they give to help us to continue providing our services. This has been essential in such difficult and challenging financial times. As always, our volunteers have provided immense help to Queenscourt. Their help, support and energy has been invaluable, and it goes without saying that we could not continue to provide the care we do without them. Our three Directors, Ms Debbie Pierce-Lawson, Dr Claire Finnegan and Mrs Louise Charnock have filled their roles magnificently this year. Queenscourt is fortunate to have such able and dedicated executive leaders. I have great confidence that we are and will remain in safe hands. Queenscourt has a well-earned reputation for excellence, and I am certain that our Directors, Staff, Trustees and Volunteers will always endeavour to maintain and enhance that reputation. **Anthony Crewe Chair of Trustees** 17/09/2024 P a g e | **3** ueenscourt QMenK￿S1nYKI wh•r• Ilf• Is for Il¥lng. 2024 1,102. 104 Patients Supported VOLUNTEERS 3,786 Hours of care provlded by Queenscourt at Home Contact5 provided by QuÈènstourt thÈrapy swrflcès for patlent5 and famllle5 747 People recelved speclallst medical, nursing and therapy support as an outpatient People were supported home from hospital on 'rapld end of Ilfe dlstharg 199 O 08.7 Average len h of stay tot ose admitted to ueenscourt ospice inpatient unit 21% 63/ 01 patients support•d di•d in ¢>￿•￿¢￿vrt Hospice OF pqti¢nt5 wpp0r￿d by Qu••nit4Wrt H•spic• di*d in their •wn home DAYS People admitted to Quèènscourt IPU for specialist support 795 New patient a55e55ments through the community specialist palliative care team Admissions to Virtual Ward 591 Patlents seen by hospital palliative care team Terence Burgess Education Centre 3,190 58 358 47 AThENDANCES AT EDUCATION SESSIONS MEDICAL STUDENTS INDIVIDUALS TRAINED IN FUTLIIE CARE PLANNING COMPLEfED CARER CHECK-IN TRAINING ££ My mum and my sister. tookgreot comfortfrom this beoutiful seThice. Our uin from losing my dad is still very row. we cannot ever. than you enough. foryour kindness. support und love Midsummer Rememljrance Service 1,671 People attended our rememberlng events. or received a form of bereavement support or contact Development of Development of VIRTUAL WARD piloL enabling same day response and enhanced multi-professional support in crlsis in the communlty FAMILY SUPPORT SERVICES Introduction of BAND 6 roles on IPU to support provision of 24 hour tele hone advice line for hea thcare professionals Appointment of a PHARMACIST Children fuclng to join the multl- professlonal palliative care team at Queenscourt reavement arers nt Introduction of ELECTRONIC PRESCRIBING Successful Partnership Award with elertronic transfer of prescriptlons directly to communlty pharmacies to improve access to medication for patients in the community Queenscourts Specialist Palliative Core SeThice won thisyearfs HCRG Successlul Partne￿hIp Award due to the difference thut our Clinical Nurse Specialist Team make. ond the'criticalfven¢fsupport thrypmvide to West Loncashire Distrirt Nursing Setvice. COLLABORATION WITH Edge Hill University We have worked with colleagues from & Le•gh ice to support the development of a c7inical plocement Jsimulation training for the new M•dicd School. Greater INVESTMENT on evidencing >>> I WANT GREAT CARE COMMUNICATIONS IMPACT VANTAGE DATA ANALYSIS **Queenscourt Hospice (Registered number 2102320)** **Report of the Trustees for the year ended 31[st] March 2024 (continued)** ## **1. What is Queenscourt and what do we do?** Queenscourt Hospice is an independent charitable organisation, and our purpose is to provide and promote the best possible consultant led, specialist palliative care for adults within West Lancashire, Southport and Formby, who are clinically referred, with the agreement of their doctor and for whose clinical needs our services are appropriate. Our services are free of charge. All our charitable activities are undertaken to further our objectives for the public benefit. We continually consider the new and innovative approaches that will best meet the needs of our local communities. Along with our clinical and medical colleagues, our service delivery is facilitated by a wide range of support from other vital members of **#teamqueenscourt.** ## **Hotel Services** All our catering is provided in-house. The catering team is particularly skilled at providing tiny, tasty, treats for those with poor appetites, liquidised and reformed food for those with swallowing difficulties and fortified food for those who struggle with volume. The catering team also provides subsidised meals for staff and TBEC. We are able to provide a high-quality service responsive to individual patient needs in bright and pleasant surroundings, including beautiful gardens, thanks to our dedicated team of volunteer gardeners. Our housekeeping team keep Queenscourt clean, working with the clinical team to ensure Infection Prevention and Control Guidance is followed. We use ultraviolet technology as needed to disinfect all clinical areas of Queenscourt Hospice. P a g e | **6** **Queenscourt Hospice (Registered number 2102320)** **Report of the Trustees for the year ended 31[st] March 2024 (continued)** ## **Corporate Services** All our patient facing services are enabled and supported by our Corporate Teams, including Administration, Human Resources and Volunteering, I.T., Communications, Information Governance, Data, Finance, Health & Safety, Estates and Income Generation. ## **2. #teamqueenscourt** Our staff and volunteers are our greatest asset. Most of our team are professionally qualified and many others are well qualified by the nature of their previous experience and the training that we provide. Our volunteer roles are many and varied. We have nearly 440 active volunteers supporting us across all areas including clinical services, catering, the community, finance, fundraising and retail. Since the pandemic we are seeing patients with increasingly complex physical, psychological, social and spiritual needs. Working as part of **#teamqueenscourt,** although immensely rewarding, can offer challenges. We offer a range of support to help with individual health and wellbeing and a key strategic objective is to ensure that we are a compassionate employer. Specific initiatives during 2023/24 have included: - Freedom to Speak Up Guardian and Champions embedded to support the staff further to ‘speak up’ or raise any concerns. - Monthly Carers group for staff and volunteers to discuss helpful information, advice and support to other carers. - Promotion of free Employee Assistance Programme (EAP) services and Wisdom App for access and support 365 days pa, including counselling and physio services - Wellbeing initiatives with awareness and information events including Menopause Week, Mental Health Awareness Week, Neurodiversity Week, relaxation sessions, yoga and meditation. - QCH staff flu vaccinations. ## **3. The future and Queenscourt Strategy[1]** As Trustees we oversee the ongoing development of our Strategic Direction. What we do now, and how we do it, will continue to be driven largely by factors that we can only hope to influence, rather than control. It is vital that we continue to engage in the regional and local landscapes of Integrated Commissioning Boards (ICB), Integrated Commissioning Partnerships (ICP), Place Based Partnerships (PBP), Primary Care Networks (PCN) and the 2 Hospice Provider Collaboratives across the ICB footprints, of which we are a member and with whom we engage in awareness raising campaigns. Following the amendment to the Health and Care Act 2022 and the development of the PEOLC Commissioning Investment Framework that defines core / specialist palliative care as the responsibility of the ICS and / or Local Authority, there has been increased media awareness. Whilst this resulted in some parliamentary debate that recognised the value that hospices bring to the whole system, this has not as yet translated into increased contribution by statutory bodies to the ever-increasing expenditure that is required to maintain and develop our service offer. As a Council we continue to balance the need for investment in service development and the needs of our local communities with the responsibility to move toward a sustainable budget. We retain a strong level of reserves and are able to use these to achieve this balance in the medium term. However, this position requires proper stewardship and an ability to accurately forecast our future financial health, allowing us to adjust our budget plans accordingly. We have mechanisms in place that allow us to accurately forecast the impact of expected or sudden fluctuations in expenditure and income over the > 1 Queenscourt Strategic Direction 2021-2026 P a g e | **7** **Queenscourt Hospice (Registered number 2102320)** **Report of the Trustees for the year ended 31[st] March 2024 (continued)** coming 3 years. Our Finance Committee uses this approach to support us in managing the significant financial risk we face, whilst still supporting service development and ensuring that we provide significant monetary contribution to the wider local health economy. ## **Our Vision, Mission, Values & Objectives** P a g e | **8** **Queenscourt Hospice (Registered number 2102320)** **Report of the Trustees for the year ended 31[st] March 2024 (continued)** ## **4. Where does our money come from?** We depend heavily upon the public within our community to provide the financial and practical support that we need to deliver the many services offered at Queenscourt. The main part of our income, whether in the form of donations or legacies, or by support for our shops, lottery and our other fundraising ventures, comes from members of the public, and we are eternally grateful to each and every one of them. We continue to receive vital support, both financial and practical, from the NHS (funding 21% of our core costs) and we are most grateful to Mersey and West Lancashire Teaching Hospitals NHS Trust and to the two new Integrated Care Boards (NHS Lancashire & South Cumbria and NHS Cheshire & Merseyside) that cover the areas we serve. We continue to work closely with the ICBs in order to foster strong working relationships and ensure good communication. We will continue to provide support to our NHS colleagues during challenging financial times. Our lottery, shops, support groups and other trading activity generated £542,284 (£543,468 in 2022/23) whilst other donations and gifts (including gift aid) raised £1,298,691 (£1,035,312 in 2022/23). Lottery income was reduced from last year (£174,314 compared to £209,292), mainly as a result of a reducing number of players (a normal occurrence). However, from July 2024 we transferred the operation of the lottery to another organisation which is expected to provide a greater net return to the hospice. Our Retail portfolio has continued to perform well this year and has been able to contribute £138,494 (just slightly down on last year’s figure of £143,954). Legacy income was £1,123,924 in 2023/24 compared to £1,206,586 the previous year. This source of income is completely unpredictable, yet it provides a substantial contribution towards our costs, without which we would have difficulty sustaining services at existing levels. ## **5. How we carry out our fundraising** Queenscourt Hospice is a member of the Fundraising Regulator and as such, we adhere to the framework that we have created to ensure respectful, open, honest and accountable fundraising. All organisations listed on the register have shown commitment to good fundraising practice, and to following the Fundraising Regulator’s “Code of Fundraising Practice” and the “Fundraising Promise”. This information is clearly available on the Queenscourt website in the “Our Supporter Promise” section: - - https://www.queenscourt.org.uk/index.php/fundraising/our supporter promise.html The Head of Income Generation and Communications is a member of The Chartered Institute of Fundraising and upholds the high standards of fundraising good practice and donor engagement that are inherent to Institute membership. Where Queenscourt works with third party organisations to fundraise for the charity, a “Commercial Participator’s Agreement” is put in place. The template used is the one recommended by the Institute of Fundraising and is a standard tripartite form of agreement between a charity, its trading company and a commercial participator. In terms of working with a third-party marketing or fundraising company, Queenscourt ensures that all contracts state that the company complies with appropriate legislation and prevailing codes of practice, e.g. those issued by the Fundraiser Regulator for face-to-face, private site and street fundraising. Queenscourt also ensures that the companies adhere to regulations of relevant governing bodies including the Gambling Commission, Institute of Fundraising and the Fundraising Regulator, for example, around Problem Gamblers and Vulnerable People. P a g e | **9** **Queenscourt Hospice (Registered number 2102320)** **Report of the Trustees for the year ended 31[st] March 2024 (continued)** Income generation has been carried out by Queenscourt Hospice Retail Limited (our shops) and Queenscourt Hospice Enterprises Limited (our lottery), the financial details of which are shown in Note 4 to our accounts. This note includes £6,103 (2022/23 £5,132) raised by our official Supporter Groups, and Enterprises incurred £46,083 (2022/23 £1,817) on the use of an external telemarketing company who contact lapsed Lottery players about their membership. In response to decreasing Lottery Membership, ageing database software and operational staff changes (including retirement of a long-standing member of the Lottery Team), alternative proposals were considered. A feasibility study subsequently concluded that an option to outsource to a third-party Lottery company should be explored in more detail, and after shortlisting and presentations by two suitable Lottery Management Companies, one of the companies was selected. The transition was made in July 2024 and Queenscourt will be one of a number of hospices throughout Great Britain supported by this company. Between 60% and 80% of profits from individuals playing in support of Queenscourt Hospice will be donated to our charity and is expected to raise at least £1.3 million over the first 5 years. All working partnerships with third party agencies are monitored throughout the duration of the partnership, and are subject to change, or indeed termination, where deemed necessary, e.g. where there is a risk of actual harm to an individual working for or supporting the charity, or a risk of reputational damage to an individual or the charity. Queenscourt is fully committed to upholding the principles stated within the following directives: DPA - Compliant with Data Protection Act 2018 GDPR – General Data Protection Regulation (Regulation (EU) 2016/679) To that effect, Queenscourt’s policy on handling data can be found on the website under the “Contact Preferences” section of “Our Supporter Promise”. The downloadable GDPR document also contains the relevant information on making a query about data processing, withdrawing consent, or initiating a complaint. Queenscourt complies with the prevailing codes of practice issued by the Fundraising Regulator, - including the Fundraising Preference Service (FPS): www.fundraisingregulator.org.uk/fundraising preference-service The FPS is a free service, run by the Fundraising Regulator, that helps individuals to end contacts with charities they no longer want to hear from. It is the UK’s only official service that helps you manage the direct marketing contact that you receive from all registered charities in England, Wales and Northern Ireland. Queenscourt’s fundraising team receives a “Weekly Report” from the FPS to notify of anyone wishing to end contact with our charity. There were no complaints received in respect of fundraising during the past year, but a procedure is in place to ensure the timely investigation and resolution of complaints should they arise. Queenscourt’s fundraising is PCI (Payment Card Industry) compliant, and the necessary attestation process is carried out on an annual basis. Queenscourt is registered with the Phone-paid Services Authority (PSA): www.psauthority.org.uk for any “Text To Donate” facility we use. This UK regulatory body is for individuals to check a phone number that they are unsure of on their phone bill. We also adhere to appropriate internal policies to ensure that all income generation activity is conducted in a compliant fashion. Queenscourt policies relevant to fundraising include: Cash Handling Support Groups; Donors Charter; Corporate Partnerships, Cash & Banking, Money Laundering & Suspicious Transactions, Social Responsibility for Gambling, Security, Data, Problem Gamblers, Vulnerable People and Complaints Policy. P a g e | **10** **Queenscourt Hospice (Registered number 2102320)** **Report of the Trustees for the year ended 31[st] March 2024 (continued)** ## **6** . **Financial Review** The Charity is showing net expenditure in 2023/24 of £541,048 which compares to net expenditure of £1,197,786 the previous year. A significant part of this change is due to investment gains of £258,856 compared to investment losses of £441,683 the previous year. Running costs increased by c.£372,000 with expenditure on the services the Hospice provides costing £13,630 per day compared to £12,611 the year before. Staffing costs, which relate directly to the services we provide, account for c.£210,000 of the increase, with additional works of repair and maintenance to the buildings and grounds increasing costs by c.£152,000. ## **7** . **Reserves and Investments** We have predicted further budget deficits for 2024/25 and future years. We work on three-year financial plans which seek to scale back our dependence on reserves and generate more income or savings on expenditure. We have reviewed and updated our designated funds which set aside money for specific purposes; these continuing to be a tangible fixed assets fund required for future depreciation charges, a budget deficit fund allocated to support a potential shortfall in the forthcoming year, a capital investment fund to support committed and planned enhancement of our assets, a contingency fund set aside in the event of non-recurring expenditure requirements and the Dr Karen Groves legacy development fund specifically aimed at seeking donations to “Keep Queenscourt in Service”. An additional designated fund has been set up this year for Specialist Palliative Care Contracts to ensure that any surplus income arising on these contracts is re-invested in this part of the service. Our general (unrestricted) fund of £5,217,911 represents our free reserves, of which up to £1,465,000 may be attributed to being held as investment property rather than cash or other listed investments. Our policy on reserves is to have a strong cash position to deal with unexpected costs and the occasional shortfall of income or difficulty with cash flow, so we aim to retain about £1.4m on short term deposit. To ensure the continuity of our services we also need a reserve to be sufficient to cover an extended operating deficit on core services for up to 2 years (i.e. current year and 12 months beyond) in order to allow time, if necessary, for us to re-organise our funding and operational strategies. At the time of setting our budget in April 2024 our worst case scenario would be for reserves to be adequate for at least 17 months beyond the current year. We recognise that with inflation and modest interest rates, cash will lose its value. Nevertheless, we believe that it is sound policy to keep some short-term cash in CCLA’s Charities Deposit Fund. This P a g e | **11** **Queenscourt Hospice (Registered number 2102320)** ## **Report of the Trustees for the year ended 31[st] March 2024 (continued)** paid an average of 4.85% during the year. However, we will consider other reputable deposit takers if better rates are available. The Trustees have wide investment powers, and our other investments are principally in two areas: CCLA’s COIF Charities Investment Fund and the BlackRock Catholic Charities Growth and Income Fund. Both funds are invested mainly in equities and aim to at least maintain their real value and to yield a regular annual income. Income from our investments has yielded around £174,000 and whilst we continue to seek ways of improving our levels of income, we will not change our conservative view of risk in order to achieve this. We do not prescribe any requirements for socially responsible investments other than to avoid tobacco shares. We also have investments in a property portfolio of 7 houses which are rented, two flats and a shop, which between them generated a net income of £59,000. ## **8. Our Constitution and Administrative Details** Queenscourt’s full name is Queenscourt Hospice. It is a Registered Charity, no. 518801, and a company limited by guarantee, registered in England No. 2102320 and incorporated in 1987. Its registered office is at Town Lane, Southport, PR8 6RE. It is not normally liable to taxation. Queenscourt Hospice has two wholly owned subsidiaries: - Queenscourt Hospice Enterprises Limited set up in 1993. It operates lotteries. Currently the chair of the board of its four directors is a member of the Hospice Council. - Queenscourt Hospice Retail Limited took over the running of our shops on 1[st] July 2006. Currently the chair of the board of its six directors is a member of the Hospice Council. - Both companies exist to pay over all their available surpluses to Queenscourt Hospice. ## The Council The members of the Council are the trustees of the charity and directors of the company. The following are trustees at the date of this report. They all served throughout the year, except where shown otherwise. Rev. P M Abrams Dr S Gardner (from 17[th] of June 2024) Mr A Appleton (from 17[th] Oct 23 to 3[rd] May 24) Ms L Hooton Ms C Bernard (Co-Chair) Mrs R Ingham (from 17[th] June 2024) Dr G Boocock Mr D Kemp Ms Y Burns (resigned 16[th] April 2024) Ms H McLaren (from 17[th] of June 2024) Ms J Campbell Mr T McGraw (Co-Chair) Ms G Causer (from 17[th] of October 23) Mrs M H Tarpey (resigned 17[th] of July 2024) Mr A Crewe (Co-Chair) Mrs A Throp (resigned 17[th] October 2023) Mr C P Cutner (Treasurer) Mr K B Wallis Company Secretary: Ms D J Lawson ## Executive Directors Medical Director: Dr Clare Finnegan, MBChB, FRCP, Dip Ethics, PGCert Teaching and Learning in Clinical Practice. She is a Consultant in Palliative Medicine for Merseycare NHS Foundation Trust and Mersey and West Lancs Teaching Hospitals NHS Trust, and Honorary Clinical Lecturer University of Liverpool and Edge Hill University. Director of Clinical Services: Mrs Louise Charnock, RGN, MSc Advanced Clinical Practice, PG Certificate in Teaching and Learning in Clinical Practice, BSc (Hons) Specialist Practitioner (District Nursing), BSc (Hons) Nursing and Health Studies, DipHE Nursing Director of Corporate Services and Company Secretary: Ms Debra Jane Lawson Dip SW, Dip HE, PG Certificate in Human Resource Development. P a g e | **12** **Queenscourt Hospice (Registered number 2102320)** ## **Report of the Trustees for the year ended 31[st] March 2024 (continued)** ## Other details: **Auditors:** MHA, Exchange Station, Tithebarn Street, Liverpool, L2 2QP **Bankers:** National Westminster Bank Plc, 130 Lord Street, Southport, PR9 0AB **Solicitors:** Hodge Halsall LLP, 2 Liverpool Road, Ainsdale, PR8 3LX Brabners Chaffe Street LLP, Horton House, Exchange Flags, Liverpool L2 3YL **Investment** CCLA Investment Management Limited. 80 Cheapside, London EC2V 6DZ **Managers:** BlackRock Investment Management (UK) Limited. 12 Throgmorton Avenue, London, EC2N 2DL ## **9. Our Governance and Administration** We are regulated by the Care Quality Commission whose reports are published and appear on our website. We were rated ‘Good’ in all areas when last inspected. We are measured against quality indicators for each of our community services subcontracts. ‘I want great care’, our survey tool and focussed discussions with patients, families help us to identify what is necessary to meet their needs. We monitor reviews and comments from our social media for more informal feedback. We also monitor evaluation materials from our Education Centre. For staff our anonymous feedback tool, ‘Thymometrics’ allows all staff to rate how it feels to be employed by Queenscourt and to give feedback anonymously to the senior team. We also have Freedom to Speak Up processes embedded and a Freedom to Speak Up Guardian in place to enable feedback from staff and volunteers. The Board Assurance Framework (BAF) is being updated and will reinforce Queenscourt’s subcommittee structure. Our BAF facilitates a clear process of monitoring and assurance for the Council of Trustees, focussed on our strategic risks and measured against key performance indicators within our strategic matrix. Our quality dashboard assists us in monitoring progress and internal scrutiny is the remit of Integrated Governance subcommittee, which includes outside professionals and two Trustees. Our governing documents are the Memorandum and Articles of Association which the Council keeps under regular review. As members of the Council, we are Trustees of the Charity and Directors of the Company. Responsibility for the management of Queenscourt is vested in the Council which meets ten times a year. We have set up governance and administrative arrangements whereby the day to day running of the hospice is delegated as appropriate to the Executive Directors who in turn attend Council meetings and subcommittees to report as necessary. A Finance subcommittee oversees the financial aspects of the charity, reviews investments and reserves and makes recommendations to the Council. Our Strategy and Succession subcommittee details our vision for 5 years at a time and our Business Plan is reviewed each year to ensure we have tangible goals to monitor. This subcommittee also considers future proofing and succession. The Visiting Group are part of our Integrated Governance subcommittee and make quarterly visits where they talk to patients, staff, volunteers, carers and families about all aspects of their experience and present an update report to the Council. The Risk & Health and Safety subcommittee oversees risk management and our approach to risk is further described below. ## **10. How we manage risk** We maintain a Risk Register and policies with defined review dates, to ensure that we keep all Queenscourt’s activities under review. We review our Risk Management Strategy annually. The Risk & Health and Safety subcommittee helps us to oversee the risks that Queenscourt faces and monitor risk management. The subcommittee meets at least 3 times per year. ## **11. Members and the Election and Appraisal of Trustees** There are some 127 members of the Company who are former or current subscribers to Queenscourt’s funds. An important function of the members is to elect or re-elect Trustees, one third of whom retire each year at the Annual General Meeting. The Council can and does recommend candidates for P a g e | **13** **Queenscourt Hospice (Registered number 2102320)** ## **Report of the Trustees for the year ended 31[st] March 2024 (continued)** election. The Council’s policy is to appraise its performance as a Council, using a learning needs analysis and the production of the Council Development Plan. At least once every 3 years the effectiveness of the Council is also reviewed against benchmarks, including the Charity Governance Code. The Co-Chairs and Trustees undertake peer reviews which inform the training and development activity that is programmed each year. We aim to maintain a good mix of skills on the Council and to give new members appropriate induction and instruction. Council subcommittees have delegated responsibility to oversee our financial performance and monitor our performance. At the date of this report, we have 14 Trustees. During the year 2023-2024 Mrs Margaret Tarpey and Ms Yvonne Burns retired as members of the Council. We would like to record our grateful thanks for the many years that they each gave in support of Queenscourt and for all their support, hard work and guidance during their time with us. ## **12. Council’s Responsibility for the Accounts** The Trustees (who are also the Directors of Queenscourt Hospice for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and regulations. Company law requires the Trustees to prepare financial statements for each financial year. Under that law the Trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable Company and the income and expenditure of the charitable Company for that period. In preparing these financial statements, the Trustees are required to: - select suitable accounting policies and then apply them consistently; - observe the methods and principles in the Charities SORP; - make judgements and accounting estimates that are reasonable and prudent; - state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable Company will continue in operation. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable Company’s transactions and disclose with reasonable accuracy at any time the financial position of the charitable Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. In so far as the Trustees are aware: - there is no relevant audit information of which the charitable Company's auditor is unaware; and - · the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information. ## **13. Auditors** Following the merger of MHA Moore & Smalley with MHA, the Charitable Company's independent auditor has now become MHA. ## **By order of the Council** **Anthony Crewe Chair** 17/09/2024 **Date:** P a g e | **14** **Queenscourt Hospice (Registered number 2102320)** ## **Independent Auditors’ Report** ## **Opinion** We have audited the financial statements of Queenscourt Hospice (the ‘parent charitable company’) and its subsidiaries (the ‘group’) for the year ended 31 March 2024 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. ## **In our opinion the financial statements:** - give a true and fair view of the state of the group and charitable company's affairs as at 31 March 2024 and of the group’s incoming resources and application of resources, including its income and expenditure, for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and - have been prepared in accordance with the requirements of the Companies Act 2006. ## **Basis for opinion** We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. ## **Conclusions relating to going concern** In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report. ## **Other information** The other information comprises the information included in the Report of the Trustees, other than the financial statements and our Report of the Independent Auditors thereon. The Trustees are responsible for the other information contained within the Report of the Trustees. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. P a g e | **15** **Queenscourt Hospice (Registered number 2102320)** ## **Independent Auditors’ Report** We have nothing to report in this regard. ## **Opinions on other matters prescribed by the Companies Act 2006** - In our opinion, based on the work undertaken in the course of the audit: - the information given in the Report of the Trustees for the financial year for which the financial statements are prepared is consistent with the financial statements; and, - the Report of the Trustees has been prepared in accordance with applicable legal requirements. In the light of the knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees. ## **Matters on which we are required to report by exception** We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us; or - the parent charitable company financial statements are not in agreement with the accounting records and returns; or - certain disclosures of trustees’ remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit. ## **Responsibilities of the trustees** As explained more fully in the Statement of Trustees’ Responsibilities, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. ## **Auditor’s responsibilities for the audit of the financial statements** Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: - Enquiries of management and those charged with governance, as well as reviewing legal and professional expenditure, to identify any evidence of actual and potential litigation and claims; - Enquiries with management and those charged with governance about any known or suspected instances of fraud; - Reviewing minutes of meetings of those charged with governance; P a g e | **16** **Queenscourt Hospice (Registered number 2102320)** ## **Independent Auditors’ Report** - Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias; and, - Auditing the risk of fraud in revenue, including through testing of donations, legacies, grants and other contractual income streams via sampling of transactions and also the use of proof in total testing. Underlying contracts have been reviewed in order to establish both that income is complete and that these are genuine income streams in which the charity has a contractual right to income, and that they have been accounted for in the correct financial period. Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibiIities. This description forms part of our Report of the Independent Auditors. ## **Use of our report** This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed. ## **Andrew Matthews BFP ACA FCCA** (Senior Statutory Auditor) ## **For and on behalf of MHA, Statutory Auditor** Exchange Station Tithebarn Street Liverpool L2 2QP 17/09/2024 Date: ______________ MHA is the trading name of MacIntyre Hudson LLP, a limited liability partnership in England and Wales (registered number OC312313) P a g e | **17** **Queenscourt Hospice (Registered company number 2102320)** ## **Consolidated Statement of Financial Activities (Incorporating an Income and Expenditure Account) For the year ended 31 March 2024** |**GROUP**
**Note**
**Income and Endowments from**
Donations and legacies
2
Charitable activities
3
Other trading activities
4
Investment income
5
Other Income – including Coronavirus grants
and Insurance claims
6
**Total income**
**Expenditure on**
Raising funds
4
Charitable activities
7
Investment property management costs
**Total expenditure**
**Net incoming / (outgoing) resources before**
**other gains and losses**
Net gains/(losses) on investments
**Net Income**
8
**Transfers between funds**
18
**Other recognised gains/(losses)**
Net gains/(losses) on disposal of assets
**Net movement in funds**
**Reconciliation of Funds**
**Total funds brought forward**
**Total Funds Carried Forward**|**Unrestricted**
**funds**
**£**
2,324,382
2,430,856
1,093,430
280,368
1,795
6,130,831
1,026,746
5,939,379
29,161
6,995,286
(864,455)
258,856
(605,599)
-
-
(605,599)
12,017,453
11,411,854|**Restricted**
**funds**
**£**
98,233
-
-
-
-
98,233
-
33,271
-
33,271
64,962
-
64,962
-
-
64,962
325,936
390,898|**Total**
**2024**
**£**
2,422,615
2,430,856
1,093,430
280,368
1,795
6,229,064
1,026,746
5,972,650
29,161
7,028,557
(799,493)
258,856
(540,637)
-
-
(540,637)
12,343,389
11,802,752|**Total**
**2023**
**Restated**
**£**
2,241,898
2,248,215
1,012,485
266,834
9,700
5,779,132
906,943
5,600,532
24,603
6,532,078
(752,946)
(441,683)
(1,194,629)
-
(1,919)
(1,196,548)
13,539,937
12,343,389| |---|---|---|---|---| ## **Continuing operations** All income and expenditure has arisen from continuing activities. A separate statement of financial activities for the Charity alone is shown with comparative figures for the previous year. The notes form part of these financial statements. P a g e | **18** **Queenscourt Hospice (Registered company number 2102320)** ## **Statement of Financial Activities (Incorporating an Income and Expenditure Account) For the year ended 31 March 2024** |**CHARITY**
**Note**
**Income and Endowments from**
Donations and legacies
2
Charitable activities
3
Other trading activities
4
Investment income
5
Other Income
6
**Total income**
**Expenditure on**
Raising funds
4
Charitable activities
7
Investment property management costs
**Total expenditure**
**Net incoming / (outgoing) resources**
**before other gains and losses**
Net gains/(losses) on investments
**Net Income**
8
**Transfers between funds**
**Other recognised gains/(losses)**
18
Net gains/(losses) on disposal of assets
**Net movement in funds**
**Reconciliation of Funds**
**Total funds brought forward**
**Total Funds Carried Forward**|**Unrestricted**
**funds**
**£**
2,324,382
2,430,856
542,284
277,908
-
5,575,430
471,756
5,939,379
29,161
6,440,296
(864,866)
258,856
(606,010)
-
-
(606,010)
12,002,258
11,396,248|**Restricted**
**funds**
**£**
98,233
-
-
-
-
98,233
-
33,271
-
33,271
64,962
-
64,962
-
-
64,962
325,936
390,898|**Total**
**2024**
**£**
2,422,615
2,430,856
542,284
277,908
-
5,673,663
471,756
5,972,650
29,161
6,473,567
(799,904)
258,856
(541,048)
-
-
(541,048)
12,328,194
11,787,146|**Total**
**2023**
**Restated**
**£**
2,241,898
2,248,215
543,468
266,320
8,442| |---|---|---|---|---| |||||5,308,343| |||||437,392
5,600,532
24,603| |||||6,062,527| |||||(754,184)
(441,683)| |||||(1,195,867)
-
(1,919)| |||||(1,197,786)
13,525,980| |||||12,328,194| ## **Continuing operations** All income and expenditure has arisen from continuing activities. The notes form part of these financial statements. P a g e | **19** **Queenscourt Hospice (Registered company number 2102320)** ## **Consolidated Balance Sheet As at 31 March 2024** |||**Total**|**Total**| |---|---|---|---| |**GROUP**|**Notes**|**2024**|**2023**| |||**£**|**£**| |**Fixed Assets**|||| |Tangible assets|11|3,112,958|3,250,859| |**Investments**|||| |Investments|12|5,242,742|6,083,886| |Investment property|13|1,465,000|1,465,000| |||9,820,700|10,799,745| |**Current Assets**|||| |Stock||823|1,327| |Debtors|14|1,321,461|1,231,015| |Cash at bank and in hand||1,369,464|1,458,322| |||2,691,748|2,690,664| |**Creditors**|||| |Amounts falling due within one year|15|(709,696)|(1,147,020)| |**Net Current Assets**||1,982,052|1,543,644| |**Total assets less current liabilities**||11,802,752|12,343,389| |**Net Assets**||11,802,752|12,343,389| |**Funds**|18||| |Unrestricted funds||11,411,854|12,017,453| |Restricted funds||390,898|325,936| |**Total Funds**||11,802,752|12,343,389| The notes form part of these financial statements. The financial statements were approved and authorised for issue by the Board of Trustees and signed on its behalf by: A Crewe - Chair C P Cutner - Treasurer Date: 17/09/2024 P a g e | **20** **Queenscourt Hospice (Registered company number 2102320)** ## **Balance Sheet As at 31 March 2024** |||**Total**|**Total**| |---|---|---|---| |**CHARITY**|**Notes**|**2024**|**2023**| |||**£**|**£**| |**Fixed Assets**|||| |Tangible assets|11|3,112,958|3,250,859| |**Investments**|||| |Investments|12|5,334,744|6,175,888| |Investment property|13|1,465,000|1,465,000| |||9,912,702|10,891,747| |**Current Assets**|||| |Debtors|14|1,435,862|1,326,197| |Cash at bank and in hand||1,049,915|1,181,349| |||2,485,777|2,507,546| |**Creditors**|||| |Amounts falling due within one year|15|(611,333)|(1,071,099)| |**Net Current Assets**||1,874,444|1,436,447| |**Total assets less current liabilities**||11,787,146|12,328,194| |**Net Assets**||11,787,146|12,328,194| |**Funds**|18||| |Unrestricted funds||11,396,248|12,002,258| |Restricted funds||390,898|325,936| |**Total Funds**||11,787,146|12,328,194| The notes form part of these financial statements. The financial statements were approved and authorised for issue by the Board of Trustees and were signed on its behalf by: A Crewe - Chair C P Cutner - Treasurer Date: 17/09/2024 P a g e | **21** **Queenscourt Hospice (Registered company number 2102320)** ## **Consolidated Cash Flow Statement For the year ended 31 March 2024** |**GROUP**
**Notes**
**Cash flows from operating activities:**
Cash generated from operations
**Net cash provided by (used in) operating activities**
**Cash flows from investing activities:**
Purchase of tangible fixed assets
Receipts from sale of tangible fixed assets
Purchase of fixed asset investments
Sale of fixed asset investments
**Increase / (Decrease) in cash and cash equivalents in the year**|**Total**
**2024**
**£**
(1,188,858)
(1,188,858)
-
-
(500,000)
1,600,000
(88,858)|**Total**
**2023**
**£**
(174,902)
(174,902)
(50,352)
795
-
-
(224,459)| |---|---|---| P a g e | **22** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Cash Flow Statement For the year ended 31 March 2024** ## **1. Reconciliation of net income/(expenditure) to net cash flow from operating activities** |**Net income/(expenditure) for the reporting period (as per the**
**statement of financial activities)**
**Adjustments for:**
Depreciation charges
(Increase)/Decrease in debtors
(Increase)/ Decrease in stock
Increase / (Decrease) in creditors
**Net cash provided by (used in) operating activities**
**. Reconciliation of net cash flow to movement in net funds**
Cash outflow / (inflow)
Movement in net funds
Net funds at 1 April 2023
**Net funds at 31 March 2024**|**2024**
**£**
(799,493)
137,901
(90,446)
504
(437,324)
(1,188,858)
**2024**
**£**
(88,858)
(88,858)
1,458,322
1,369,464|**2023**
**£**
(752,946)
155,664
(287,340)
423
709,297| |---|---|---| |||(174,902)
**2023**
**£**
(224,459)| |||| |||(224,459)
1,682,781| |||1,458,322| ## **2. Reconciliation of net cash flow to movement in net funds** ## **3. Analysis of net funds** |Cash at bank and in hand|**At 1 April**
**2023**
**£**
1,458,322
1,458,322|**Cashflow**
**£**
(88,858)
(88,858)|**At 31**
**March**
**2024**
**£**
1,369,464| |---|---|---|---| ||||1,369,464| P a g e | **23** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **1 Accounting policies** ## **Basis of preparing the financial statements** The financial statements of the group and parent charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 October 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention with the exception of investments which are included at market value. The financial statements are presented in sterling which is the functional currency of the charity. The statement of financial activities (SOFA) and balance sheet consolidate the financial statements of the Charity and its subsidiary undertakings. The results of the subsidiary undertakings are consolidated on a line by line basis. The Charity is a company limited by guarantee. The members of the company include the trustees named in the report of the trustees. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the Charity. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. Legacies and grants are recognised in the Statement of Financial Activities when they become receivable and it is reasonably certain that they will be received and can be measured with sufficient reliability. Income tax is recoverable monthly on completion of the documentation. Income is deferred only when the Charity has to fulfil conditions before becoming entitled to it. Gifts in kind are included at valuation, with the exception of food where the total involved is not material. Goods donated for resale are included as income when sold. No amounts are included in the financial statements for services donated by volunteers. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. The expenses of operating the Charity shops including depreciation of fixed assets employed in the shops relate entirely to fundraising. Also included in fundraising are separately identifiable expenses incurred at the main hospice building and in local support groups in connection with specific fundraising activities. ## **Tangible fixed assets** All assets costing more than £5,000 are capitalised. Assets costing less than this are written off within 12 months. Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. P a g e | **24** **Queenscourt Hospice (Registered company number 2102320)** **Notes to the Financial Statements For the year ended 31 March 2024** ## **1 Accounting policies (continued)** Freehold Land: NIL Freehold Buildings: Between 2% and 4% per annum of cost Leasehold Improvements: 10% per annum of cost Equipment: Between 5% and 50% per annum of cost Fixtures and Fittings: Between 4% and 20% per annum of cost Motor Vehicles: Between 17% and 20% per annum of cost ## **Investments** Fixed asset investments and shares are included at market value at the balance sheet date. Investment property is shown at most recent valuation. The Statement of Financial Activities includes the net gains and losses arising on revaluations and disposals throughout the year. ## **Debtors** Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. ## **Creditors** Creditors are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured reliably. Creditors are normally recognised at their settlement amount after allowing for any trade discounts due. ## **Financial instruments** The Group only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Designated funds comprise unrestricted funds that have been set aside by the trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **Pension costs and other post-retirement benefits** The Group contributed to the personal pension plans of 142 (2023: 137) of its employees. The pension cost charge represents contributions for the period payable to by the Group. Superannuation employers’ contributions are paid for employees remaining in the NHS pension scheme. P a g e | **25** **Queenscourt Hospice (Registered company number 2102320)** **Notes to the Financial Statements For the year ended 31 March 2024** ## **1 Accounting policies (continued)** ## **Operating leases** Rentals applicable to operating leases are charged to the SOFA on a straight line basis over the term of the lease. ## **Taxation** The Company is a registered charity and consequently there is no liability to taxation. The subsidiary companies are subject to UK Corporation Tax on profits not covenanted to the parent charity. ## **Government grants** Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability. ## **Judgements and key sources of estimation uncertainty** In the application of the Group’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. The trustees believe that the following estimates and assumptions are significant in respect of the carrying amount of assets and liabilities: ## **Valuation of investment properties** Investment properties held by the group are reviewed annually by the trustees, utilising the advice from a local estate agent, but not a professional valuer. The trustees consider local market factors and rental yields when reviewing the fair value of investment properties, as well as the opinion of local estate agents. Given the uniqueness of the organisational property portfolio, the trustees appreciate the inherent difficulties and uncertainties around applying a fair value to the investment property portfolio, however, feel experienced enough to do this annually. ## **Recognition of legacy income** Throughout the year the trustees maintain a register of notifications of legacy income to be received, bequeathed by our valued donors. At each year end date, the trustees must provide for a figure of legacy income receivable, when its value and receipt is both measurable and probable. Whilst constrained by both the legal process and other market factors, such as property values, the trustees feel confident that their experience allows them to make accurate estimations and judgements around this future right to income in respect of legacies. P a g e | **26** **Queenscourt Hospice (Registered company number 2102320)** **Notes to the Financial Statements For the year ended 31 March 2024** ## **Going concern** The trustees assess whether the use of going concern is appropriate for the preparation of these accounts, i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the Group to continue as a going concern. The trustees make this assessment in respect of a period of at least one year from the date of authorisation for issue of the financial statements. The trustees prepared a 3 year budget in April and also carried out an impact assessment in the event of budget plans falling short of expectations. These 3 year forecasts are also updated at each quarterly budget monitoring review by the finance committee. Queenscourt Hospice Enterprise Ltd intends to cease operating the Lottery in the summer of 2024 and transfer the entire business to an external operator. The company directors and the trustees are confident that the company will be solvent at the point of transfer of the business and should be able to meet all its financial obligations thereafter. As a consequence, the trustees have concluded that the Group has adequate resources to continue in operational existence for the foreseeable future and there are no material uncertainties about the Group’s ability to continue as a going concern, thus they continue to adopt the going concern basis of accounting in preparing the financial statements. ## **2 Donations and Legacies** |**GROUP AND CHARITY**
Donations
Legacies
Remembrance gifts
Gift Aid
Regular and other donations including GAYE|**2024**
**£**
345,650
1,123,924
173,903
114,160
664,978
2,422,615|**2023**
**£**
156,130
1,206,586
178,784
110,318
590,080| |---|---|---| |||2,241,898| Legacy income includes £1,107 restricted to funding Queenscourt at Home (2023: £95,000 restricted for future building acquisitions). ## **3 Income from charitable activities** |
**Income from charitable activities**||| |---|---|---| |**GROUP AND CHARITY**
NHS Cheshire & Merseyside and Lancashire & South Cumbria ICBs
Other External Funding
Medical Income and Course Fees
Total|**2024**
**£**
1,137,701
1,086,838
206,317
2,430,856|**2023**
**£**
990,769
1,018,509
238,937| |||2,248,215| Income from the Integrated Care Boards includes £124,371 (2023: £nil) Virtual Ward pilot (Lancs & S Cumbria). The balance of £1,013,330 (2023: £990,769) represents a contribution of around 21% (2023: 22%) to the core costs of the Hospice including Queenscourt at Home. P a g e | **27** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **4 Other Trading Activities** Queenscourt Hospice Enterprises Limited, a wholly owned subsidiary company, operates lotteries. The Charity owns the issued share capital of 2 fully paid shares of £1 each (2023: 2 shares) Queenscourt Hospice Retail Limited, a wholly owned subsidiary company, manages the charity shops. The Charity owns the issued share capital of 92,000 fully paid shares of £1 each. (2023: 92,000 shares). An analysis of Group fundraising income and expenditure is shown below: |Income
Covenant Income
Recharges to Subsidiary
**Total Fundraising Income**
Sundry income
Commission - gift-aided sales
Recharge to charity
Deposit Interest
**Sub total**
Fundraising Trading Costs
Recharges from Parent
Covenanted to Charity
Net Profit
Tax charge
**Profit after Tax**
**Reserves as at 31 March 2024**|**Retail**
**2024**
**£**
497,933
-
-
497,933
738
1,057
104,436
1,872
606,036
(432,007)
(35,124)
(138,494)
411
-
411
1,103|**Lottery**
**2024**
**£**
406,185
-
-
406,185
-
-
-
588
406,773
(227,419)
(5,040)
(174,314)
-
-
-
14,503|**Support**
**Groups**
**and other**
**trading**
**2024**
**£**
189,312
312,808
40,164
542,284
-
-
-
-
542,284
(471,756)
-
-
70,528
-
70,528|**Group**
**Total 2024**
**£**
1,093,430
-
-
1,093,430
738
1,057
-
2,460
1,097,685
(1,026,746)
-
-
70,939
-
70,939|**Group**
**Total 2023**
**£**
1,012,485
-
-
1,012,485
1,258
-
514
1,014,257
(906,943)
-
-
107,314
-
107,314| |---|---|---|---|---|---| The Retail subsidiary has generated income of £26,112 (2023: £27,990) from gift aided donations. P a g e | **28** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **5 Investment Income** |**GROUP**
Interest income
Rents from investment property
**CHARITY**
Interest income
Rents from investment property
**Other Income**
**GROUP**
Commission on gift-aided sales (Unrestricted)
Sundry income (Unrestricted)
Insurance claims (Unrestricted)
NHSE Hospice UK (Restricted)
**CHARITY**
NHSE Hospice UK (Restricted)|**2024**
**£**
192,423
87,945
280,368
189,963
87,945
277,908
**2024**
**£**
1,057
738
-
-
1,795
**2024**
**£**
-
-|**2023**
**£**
192,276
74,558| |---|---|---| |||266,834| |||191,762
74,558| |||266,320| |||**2023**
**£**
1,258
-
8,442| |||9,700| |||**2023**
**£**
8,442| |||8,442| ## **6 Other Income** P a g e | **29** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **7 Costs of charitable activities** ## **GROUP AND CHARITY** |**Direct costs**
Staff costs
Training & IT support
Premises
General office exps
Nursing supplies
Food
Cleaning and laundry
Transport and travel
Other expenses
Auditors’ remuneration
Bank charges
Other professional
fees
Contract management
Depreciation
**Support costs**
**reallocated**|**Inpatient**
**Services**
**£**
1,204,778
2,348
50,152
610
25,778
-
1,652
205
12,451
-
-
1,119
-
-
1,299,093
453,702
1,752,795|**Queens**
**-court**
**at Home**
**£**
492,415
863
3,257
2,076
97
-
-
15,742
2,614
-
-
1,200
-
-
518,264
105,167
623,431|**Other**
**Clinical**
**Services**
**£**
947,320
8,784
11,089
4,446
1,322
37,375
1,593
9,467
4,658
-
-
4,870
-
2,411
1,033,335
307,824
1,341,159|**Education**
**£**
386,835
11,356
4,737
5,143
-
954
-
396
274
-
-
433
-
15,362
425,490
148,930
574,420|**Medical**
**Services**
**£**
642,505
2,154
910
1,798
-
-
-
-
3,368
-
-
1,248
-
-
651,983
120,256
772,239|**Contracted**
**community**
**services**
**£**
884,010
(998)
6,064
1,783
122
-
-
14,950
2,479
-
-
196
75,463
-
984,069
(75,463)
908,606|**Support**
**Services**
**£**
614,233
7,006
274,872
20,397
-
-
16,029
368
65,049
9,513
3,270
5,014
(75,463)
120,128
1,060,416
(1,060,416)
-|**2024**
**Total**
**activities**
**£**
5,172,096
31,513
351,081
36,253
27,319
38,329
19,274
41,128
90,893
9,513
3,270
14,080
-
137,901
5,972,650
-
5,972,650|**2023**
**Restated**
**Total**
**activities**
**£**
4,962,173
54,734
183,689
38,711
23,769
27,530
33,113
36,907
52,931
8,971
5,032
18,240
-
154,732| |---|---|---|---|---|---|---|---|---|---| ||||||||||5,600,532
-| ||||||||||5,600,532| |**Allocation of support**
**costs**
Fixed price recharges
Human Resources
Communications
Data
Estates
Finance
Housekeeping
IT/IG
Volunteering
Corporate other
Depreciation
Other staff-related
Other premises related
Total
reallocated
to
above table|**Inpatient**
**Services**
**£**
-
44,107
5,239
13,327
131,190
61,558
45,647
22,831
9,537
43,023
67,972
(6,996)
16,267
453,702|**Queens**
**-court**
**at Home**
**£**
-
18,027
2,141
5,447
14,027
25,160
4,881
9,332
3,898
17,584
5,790
(2,859)
1,739
105,167|**Other**
**Clinical**
**Services**
**£**
-
34,681
4,120
10,479
82,962
48,403
28,867
17,952
7,499
33,829
34,246
(5,501)
10,287
307,824|**Education**
**£**
-
14,162
1,682
4,279
59,160
19,765
20,585
7,331
3,062
13,814
-
(2,246)
7,336
148,930|**Medical**
**Services**
**£**
-
23,522
2,795
7,108
3,675
32,828
1,278
12,176
5,085
22,944
12,120
(3,731)
456
120,256|**Contracted**
**community**
**services**
**£**
(75,463)
(75,463)|**Corporate**
**and Other**
**Costs**
**£**
(75,463)
134,499
15,977
40,640
291,014
187,714
101,258
69,622
29,081
131,194
120,128
(21,333)
36,085
1,060,416|**Method of**
**allocation**
Agreed price
Staff costs
Staff costs
Staff costs
Floor area
Staff costs
Floor area
Staff costs
Staff costs
Staff costs
Floor area
Staff costs
Floor area| |---|---|---|---|---|---|---|---|---| |||||||||| P a g e | **30** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **Governance costs** The following costs in respect of the Governance of the Charity are included in the preceding tables: ||**2024**|**2023**| |---|---|---| |||**Restated**| ||**£**|**£**| |Auditors' remuneration for audit of the accounts|9,513|8,721| |Auditors' remuneration for non-audit work|-|250| |Staffing|176,800|175,350| |Vantage IT system|5,000|-| ||________|________| ||191,313|184,321| ## **8 Net income/(expenditure)** ## **GROUP** Net income/(expenditure) is stated after charging/(crediting): |**ROUP**
et income/(expenditure) is stated after charging/(crediting):||| |---|---|---| ||**2024**|**2023**| ||**£**|**£**| |Auditors' remuneration|14,508|13,671| |Auditors' remuneration for non-audit work|912|1,966| |Depreciation - owned assets|137,901|155,664| |Rentals – operating lease – Property|107,994|96,645| |Rentals - operating lease - Equipment|5,637|7,151| ## **CHARITY** Net income/(expenditure) is stated after charging/(crediting): ||**2024**|**2023**| |---|---|---| ||**£**|**£**| |Auditors' remuneration|9,513|8,721| |Auditors' remuneration for non-audit work|-|250| |Depreciation - owned assets|137,901|154,732| |Rentals – operating lease – Property|107,994|96,645| |Rentals - operating lease|5,637|7,151| ## **9 Trustee’s renumeration and benefits** There were no trustees renumeration or other benefits for the year ended 31 March 2024 nor for the year ended 31 March 2023. ## **Trustees' expenses** No Council members received re-imbursed expenses (2023: £nil). P a g e | **31** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** |**10**
**Staff costs**
**GROUP**
Wages and salaries
Social security costs
Other pension costs
The average monthly number of employees during the year was as follows:
**GROUP**
**Full time**
**Part time**
**Bank**
Medical
3
4
-
Nursing
31
39
8
Therapists
3
2
-
Catering
1
5
-
Housekeeping
1
5
-
Fundraising & administration
8
30
1
Education
4
5
1
Maintenance
2
-
-
Retail
5
1
7
Lottery
-
2
1
58
93
18
**CHARITY**
Wages and salaries
Social security costs
Other pension costs|**2024**
**2023**
**Restated**
**£**
**£**
4,815,963
4,632,876
473,833
469,623
401,005
356,898
5,690,801
5,459,397
**Total 2024**
**Total 2023**
7
8
78
74
5
4
6
5
6
6
39
38
10
9
2
1
13
15
3
4
169
164
**2024**
**2023**
**Restated**
**£**
**£**
4,577,126
4,397,476
458,074
454,488
396,528
351,986
5,431,728
5,203,950|**2023**
**Restated**
**£**
4,632,876
469,623
356,898
5,459,397
**2023**
**Restated**
**£**
4,397,476
454,488
351,986| |---|---|---| |||5,203,950| P a g e | **32** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** |**CHARITY**
Medical
Nursing
Therapists
Catering
Housekeeping
Fundraising & Administration
Education
Maintenance|**Full time**
3
31
3
1
1
8
4
2
53|**Part time**
4
39
2
5
5
30
5
-
90|**Bank**
-
8
-
-
-
1
1
-
10|**Total 2024**
7
78
5
6
6
39
10
2
153|**Total 2023**
8
74
4
5
6
38
9
1| |---|---|---|---|---|---| ||||||145| Staff numbers exclude 14 (2023: 14) Council members, who are all non-executive Directors of the organisation. The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was: |
60,000 was:||| |---|---|---| ||**2024**|**2023**| |£60,000 - £70,000|11|1| |£70,001 - £80,000|1|1| |£80,001 - £90,000|2|1| |£90,001 - £100,000|-|-| |£100,001 - £110,000|-|-| |£110,001 - £120,000|1|2| |£120,001 - £130,000|2|1| |£130,001 - £140,000|1|1| The key management personnel comprise of the 3 Executive Directors being the Medical Director, the Director of Nursing Services and the Corporate Services Director with total employee benefit costs of £216,280 (2023: £187,306). In addition, a great amount of time, the value of which is impossible to reflect in these financial statements, is donated by volunteers. Along with a standard defined contribution scheme, the company operates an exempt approved defined benefit scheme, namely the National Health Superannuation Scheme. The assets of this scheme are held separately and contributions to the scheme are charged to the statement of financial activities so as to spread the cost of pensions over employees’ working lives with the company. This scheme does not have a real pension fund, but as a statutory scheme, benefits are fully guaranteed by the Government. Contributions from both members and employers are paid to the Exchequer, which meet the cost of increasing benefits each year by the rate of inflation. This extra cost is not met by contributions from scheme members and employers, As a result of the nature of the scheme there are no separately identifiable assets and liabilities which can be identified as relating to Queenscourt Hospice therefore, as permitted by FRS102, the scheme has been accounted for as a defined contribution scheme. The contributions to the superannuation scheme were substantially defrayed by the Integrated Care Boards (formerly Clinical Commissioning Groups). P a g e | **33** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** |**11**
**Tangible fixed assets**
**GROUP**
**Cost**
At 1 April 2023
Additions
Disposals
At 31 March 2024
**Depreciation**
At 1 April 2023
Charge for year
Eliminated on disposal
At 31 March 2024
**Net book value**
At 31 March 2024
At 31 March 2023|**Freehold**
**property**
**£**
4,154,739
-
-|**Fixtures &**
**fittings**
**£**
838,287
-
-|**Equipment**
**£**
320,949
-
(1,539)|**Totals**
**£**
5,313,975
-
(1,539)| |---|---|---|---|---| ||4,154,739
1,297,979
91,993
-|838,287
531,036
33,531
-|319,410
234,101
12,377
(1,539)|5,312,436
2,063,116
137,901
(1,539)| ||1,389,972
2,764,767
2,856,760|564,567
273,720
307,251|244,939
74,471
86,848|2,199,478
3,112,958
3,250,859| P a g e | **34** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** |**11**
**Tangible fixed assets (continued)**
**CHARITY**
**Freehold**
**property**
**£**
**Cost**
At 1 April 2023
4,150,529
Additions
-
Disposals
-
At 31 March 2024
4,150,529
**Depreciation**
At 1 April 2023
1,293,769
Charge for year
91,993
Eliminated on disposal
-
At 31 March 2024
1,385,762
**Net book value**
At 31 March 2024
2,764,767
At 31 March 2023
2,856,760|**11**
**Tangible fixed assets (continued)**
**CHARITY**
**Freehold**
**property**
**£**
**Cost**
At 1 April 2023
4,150,529
Additions
-
Disposals
-
At 31 March 2024
4,150,529
**Depreciation**
At 1 April 2023
1,293,769
Charge for year
91,993
Eliminated on disposal
-
At 31 March 2024
1,385,762
**Net book value**
At 31 March 2024
2,764,767
At 31 March 2023
2,856,760|**Fixtures &**
**fittings**
**£**
838,287
-
-|**Equipment**
**£**
317,390
-
-|**Totals**
**£**
5,306,206
-
-| |---|---|---|---|---| ||4,150,529
1,293,769
91,993
-|838,287
531,036
33,531
-|317,390
230,542
12,377
-|5,306,206
2,055,347
137,901
-| ||1,385,762
2,764,767
2,856,760|564,567
273,720
307,251|242,919
74,471
86,848|2,193,248
3,112,958
3,250,859| Included in cost or valuation of land and buildings is freehold land of £30,000. All tangible fixed assets are used for direct charitable purposes except for shop and lottery equipment which have net book values of £nil (2023: £nil) and are used for fundraising purposes. P a g e | **35** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** |**12**
**Fixed asset investments**
**GROUP**
**Market value**
At 1 April 2023
Additions
Disposals
Revaluations
At 31 March 2024
**Net book value**
At 31 March 2024
At 31 March 2023
**CHARITY**
**Market value**
At 1 April 2023
Additions
Disposals
Revaluations
At 31 March 2024
**Net book value**
At 31 March 2024
At 31 March 2023|**Shares in**
**group**
**undertakings**
**£**
-
-
-
-
-
-
-
**Shares in**
**group**
**undertakings**
**£**
92,002
-
-
-
92,002
92,002
92,002|**Listed**
**investments**
**£**
6,083,886
500,000
(1,600,000)
258,856
5,242,742
5,242,742
6,083,886
**Listed**
**investments**
**£**
6,083,886
500,000
(1,600,000)
258,856
5,242,742
5,242,742
6,083,886|**Totals**
**£**
6,083,886
500,000
(1,600,000)
258,856| |---|---|---|---| ||||5,242,742
5,242,742
6,083,886
**Totals**
**£**
6,175,888
500,000
(1,600,000)
258,865| ||||5,334,744
5,334,744
6,175,888| There were no investment assets held outside the UK. P a g e | **36** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** |**13**
**Investment Property**
**GROUP AND CHARITY**
**Market value**
At 1 April 2023
Additions
Disposals
Revaluations
At 31 March 2024
**Net book value**
At 31 March 2024
At 31 March 2023|**Totals**
**£**
1,465,000
-
-
-| |---|---| ||1,465,000
1,465,000
1,465,000| ## **14 Debtors: Amounts falling due within one year** |**GROUP**
Trade and other debtors
Prepayments and accrued income
Income tax recoverable
VAT reclaim|**2024**
**£**
5,456
1,282,323
11,076
22,606
1,321,461|**2023**
**£**
217,117
983,727
8,517
21,654| |---|---|---| |||1,231,015| P a g e | **37** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **14 Debtors: Amounts falling due within one year (continued)** |**CHARITY**
Amounts owed by group undertakings
Trade debtors
Prepayments and accrued income
Income tax recoverable
VAT reclaim
**5**
**Creditors: Amount falling due within one year**
**GROUP**
Trade and other creditors
Accruals and deferred income
**CHARITY**
Trade and other creditors
Accruals and deferred income|**2024**
**£**
142,495
5,456
1,254,229
11,076
22,606
1,435,862
**2024**
**£**
264,548
445,148
709,696
**2024**
**£**
223,958
387,375
611,333|**2023**
**£**
123,350
217,117
955,559
8,517
21,654| |---|---|---| |||1,326,197| |||**2023**
**£**
330,453
816,567| |||1,147,020| |||**2023**
**£**
254,532
816,567| |||1,071,099| ## **15 Creditors: Amount falling due within one year** P a g e | **38** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **16 Leasing agreements** ## **Lessee** Minimum lease payments under non-cancellable operating leases fall due as follows: |**GROUP/ CHARITY**
Expiring:
Within one year
Between two and five years
More than five years|**Land**
**2024**
**£**
78,283
192,000
-|**& Buildings**
**2023**
**£**
79,471
205,782
47,079
332,332|**Other operating leases**
**2024**
**2023**
**£**
**£**
4,864
3,590
15,747
13,400
-
601
20,611
17,591|**Other operating leases**
**2024**
**2023**
**£**
**£**
4,864
3,590
15,747
13,400
-
601
20,611
17,591| |---|---|---|---|---| ||270,323||20,611|17,591| ## **Lessor** The operating leases represent leases of properties to third parties. These leases are negotiated over terms between 6 months and 1 year. There are options for both parties to extend the lease terms. At the reporting end date the charity had contracted with tenants for the following minimum lease payments: |**GROUP**
Expiring:
Within one year|**2024**
**£**
6,735
6,735|**2023**
**£**
11,610| |---|---|---| |||11,610| P a g e | **39** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** **17 Analysis of net assets between funds** |**7**
**Analysis of net assets between funds**|**7**
**Analysis of net assets between funds**|||| |---|---|---|---|---| |**GROUP**
**Unrestricted**
**funds**
**£**
Fixed assets
3,112,958
Investments
6,707,742
Current assets
2,300,850
Current liabilities
(709,696)
11,411,854
**CHARITY**
**Unrestricted**
**funds**
**£**
Fixed assets
3,112,958
Investments
6,799,744
Current assets
2,094,879
Current liabilities
(611,333)
11,396,248||**Restricted**
**funds**
**£**
-
-
390,898
-
390,898
**Restricted**
**funds**
**£**
-
-
390,898
-
390,898|**2024 Total**
**funds**
**£**
3,112,958
6,707,742
2,691,748
(709,696)|**2023 Total**
**funds**
**£**
3,250,859
7,548,886
2,690,664
(1,147,020)| ||||11,802,752
**2024 Total**
**funds**
**£**
3,112,958
6,799,744
2,485,777
(611,333)|12,343,389
**2023 Total**
**funds**
**£**
3,250,859
7,640,888
2,507,546
(1,071,099)| ||11,396,248||11,787,146|12,328,194| P a g e | **40** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **18 Movement in funds** ## **Designated Funds** Designated Funds represent a part of the Unrestricted Funds that have been set-aside by the Trustees for specific purposes, these being: ## **Tangible Fixed Assets** This is required in order to fund future depreciation charges. **Budget Deficit** This is to provide cover for the forthcoming year’s forecast deficit with the exception of depreciation charges which are included within tangible fixed assets. **Capital Investment** This is to provide funds for both committed and planned capital investment with the exception of where the Charity are holding any restricted funds for this purpose. **The Dr Karen Groves** This fund was launched 2023 with the objective of boosting support **Legacy Development** to keep Queenscourt in service. Contributions to the fund are for **Fund** general use and are not restricted. **Specialist Palliative** This fund has been set up so that any profits earned on these **Care Contracts** contracted services can be carried forward and applied to support expenditure or losses in future years and ensure that at no point will the Hospice be supporting the contracts from charitable funds. **Contingency** This comprises funds set aside in the event that any future organisational restructure may require non-recurring expenditure. P a g e | **41** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **18 Movement in funds (continued)** |**8**
**Movement in funds (continued)**||||| |---|---|---|---|---| |**CHARITY**
**Unrestricted funds**
General fund
Designated Fund
-
Tangible Fixed Assets
-
Budget Deficit
-
Capital Investment
-
Dr Groves Development Fund
-
Specialist Palliative Care Contracts
-
Contingency
**Restricted funds**
Restricted funds
**Total funds**
**GROUP**
**Unrestricted funds**
General fund
Designated Fund
-
Tangible Fixed Assets
-
Budget Deficit
-
Capital Investment
-
Dr Groves Development Fund
-
Specialist Palliative Care Contracts
-
Contingency
**Restricted funds**
Restricted funds
**Total funds**|**At 1 April**
**2023**
**£**
6,056,594
3,250,859
1,499,000
211,000
-
-
1,000,000|**Net**
**movement**
**in funds**
**£**
(619,401)
-
-
-
13,391
-
-
(606,010)
64,962
(541,048)
**Net**
**movement**
**in funds**
**£**
(618,990)
-
-
-
13,391
-
-
(605,599)
64,962
(540,637)|**Transfers**
**between**
**funds**
**£**
(204,087)
(137,901)
463,611
(211,000)
(13,391)
102,768
-|**At 31**
**March**
**2024**
**£**
5,233,517
3,112,958
1,962,611
-
-
102,768
1,000,000| ||**At 1 April**
**2023**
**£**
6,041,399
3,250,859
1,499,000
211,000
-
-
1,000,000
12,017,453
325,936
12,343,389||**Transfers**
**between**
**funds**
**£**
(204,087)
(137,901)
463,611
(211,000)
(13,391)
102,768
-
-
-
-|**At 31**
**March**
**2024**
**£**
5,217,911
3,112,958
1,962,611
-
-
102,768
1,000,000
11,411,854
390,898
11,802,752| ||12,002,258
325,936
12,328,194||-
-
,-|11,396,248
390,898
11,787,146| P a g e | **42** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** ## **18 Movement in funds (continued)** Net movement in funds, included in the above are as follows: |**GROUP**
**Unrestricted funds**
Unrestricted funds
**Restricted funds**
Restricted funds
**Total funds**
**CHARITY**
**Unrestricted funds**
Unrestricted funds
**Restricted funds**
Restricted funds
**Total funds**|**Incoming**
**resources**
**£000**
6,130,831
98,233
6,229,064
**Incoming**
**resources**
**£**
5,575,430
98,233
5,673,663|**Resources**
**expended**
**£’000**
(6,995,286)
(33,271)
(7,028,557)
**Resources**
**expended**
**£**
(6,440,296)
(33,271)
(6,473,567)|**Gains and**
**losses**
**£’000**
258,856
-
258,856
**Gains and**
**losses**
**£**
258,856
-
258,856|**Movement**
**in funds**
**£’000**
(605,599)
64,962
(540,637)
**movement**
**in funds**
**£**
(606,010)
64,962
(541,048)| |---|---|---|---|---| P a g e | **43** **Queenscourt Hospice (Registered company number 2102320)** ## **Notes to the Financial Statements For the year ended 31 March 2024** An analysis of Restricted Funds is shown below |Equipment
Others
Staff Benevolent Fund
Grounds, Furniture, Man Shed
Education Fund
Compassionate Communities
Training
Fixtures & Fittings
Bequest for purchase of a
property
for
Retail
or
for
generating rental income|**Opening**
**balance**
**£**
11,897
12,247
37
1,993
34,816
12,300
7,646
245,000|**Income**
**£’000**
13,260
8,741
2,000
-
-
-
74,232
-|**Capital**
**Expenditure**
**£’000**
-
-
-
-
-
-
-
-
-|**Revenue**
**Expenditure**
**£’000**
(14,854)
(9,351)
(2,000)
(1,321)
(4,035)
-
(1,710)
-|**Closing**
**balance**
**£’000**
10,303
11,637
37
672
30,781
12,300
80,168
245,000| |---|---|---|---|---|---| ||325,936|98,233||(33,271)|390,898| ## Equipment: This fund relates to monies received for the purchase of equipment for all areas of the Hospice. ## Others: Other service funds represent monies received for the provision of specific Hospice services. ## Staff Benevolent Fund: This fund relates to donations given specifically of the benefit of staff. ## Grounds, Furniture, Man Shed: This fund relates to funds received for the purchase and maintenance of garden equipment/furniture for the Hospice. ## Education Fund: This fund is used to support staff in learning new skills, increase knowledge and skillsets to better meet the needs of the communities and the Hospice. ## Compassionate Communities Training: This fund relates to training and supporting Compassionate Community Connectors who support the wellbeing of their community through compassionate conversations and encouraging social connections. ## Fixtures & Fittings: This fund relates to monies received for the purchase of fixtures and fittings for the Hospice. P a g e | **44** **Queenscourt Hospice (Registered company number 2102320)** **Notes to the Financial Statements For the year ended 31 March 2024** ## **18 Movement in funds (continued)** ## The Big Give Campaign This relates to funds raised through the Big Give campaign 2023 for improvements for the comfort of patients and particularly for heating. ## Bequest for purchase of a property for Retail or for generating rental income: This fund is specifically for the purchase of retail property with the object of reducing the amount spent on renting such property or the purchase of retail or residential property for the purposes of generating income. ## **19 Contingent liabilities** The Charity has undertaken to repay any legitimate claims in respect of donated, unclaimed client monies/bequests of £4,000 (2023: £35,215). ## **20 Contingent assets** Within the year there were material contingent assets of £76,000 (2023: £376,000) in respect of legacies to which the charity has a future right to income, but which are contingent upon certain legal processes completing in a future period. As such, the probability and measurement of these legacies is not reliable enough to provide in full for these assets at this point in time. ## **21 Capital commitments** At the year end Queenscourt Hospice had the following capital commitments: |**GROUP**
Authorised and contracted for
Authorised and not contracted for
**CHARITY**
Authorised and contracted for
Authorised and not contracted for|**2024**
**£**
-
-
-
**2024**
**£**
-
-
-|**2023**
**£**
-
11,000| |---|---|---| |||11,000| |||**2023**
**£**
-
11,000| |||11,000| P a g e | **45** **Queenscourt Hospice (Registered company number 2102320)** **Notes to the Financial Statements For the year ended 31 March 2024** ## **22 Related party transactions** On consolidation all transactions and closing balances with wholly owned subsidiary entities are netted against each other. The Trustees review Related Parties on a regular basis and deem no further transactions in the period to require disclosure. ## **23 Donated goods** Queenscourt Hospice Retail Ltd acts as an agent in selling donated goods and charged commission of £1,057 (2023: £1,258) for these services. ## **24 Drugs** NHS Cheshire & Merseyside Integrated Care Board contributed £39,126 (2023: £34,530) towards drugs supplied by Southport and Ormskirk NHS Trusts. ## **25 Prior period adjustments** There are two small adjustments to the consolidated (group) accounts which are deemed as immaterial. The Consolidated Statement of Financial Activities (for both the Group and Charity) has an additional expenditure line for the costs of investment property management. This figure of £24,603 has been deducted from expenditure on charitable activities. This also affects note 7 to the accounts. In note 7 to the accounts, travel expenses (£36,827) have been taken out of staff costs and are now included in the transport and travel heading. Accordingly, the staff costs in note 10 (for both the Group and the Charity) have been reduced by this amount. Note 7 has now been expanded to fully reflect the costs of Governance of the Charity. Note 3 to the accounts has been adjusted by £160,152 so as to include End of Life Monies received from Cheshire and Merseyside ICB in the NHS Cheshire & Merseyside and Lancashire & South Cumbria ICBs line, having been removed from the line for Medical Income and Course Fees. All adjustments made in respect of the prior year are restatement and presentational only, there has been no effect on the surplus/(deficit) previously reported by the Parent Charity (the Group) or its subsidiaries. P a g e | **46** 01704 544645 hospice@queenscourt.org.uk queenscourt.org.uk ueenscourt Hospice, Town Lane, Southport, PR8 6RE ueenscourt Hospice where life 15 for living... Registered Office: Queenscourt Hospice l Town Lane I Southport | PR8 6RE Company Limited by guarantee and registered in England No. 2102320 | Registered Charity No. 518801